Xavier Forns

Has grant

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Xavier Forns is an Associate Professor at Universitat de Barcelona, Spain. His research focuses on liver diseases, particularly regarding hepatitis and Wilson disease, as highlighted in his recent articles. He has contributed to the understanding of drug-induced liver conditions, the silent risks of hepatitis E, and the implications of herbal supplement use among liver patients. Additionally, he emphasizes the need for innovative methodologies in the assessment of copper levels in relation to liver health.

Recent Grants

Grant: Close

Evaluación prospectiva de un modelo externalizado de consulta especializada con intervención educacional para reducir la reinfección por el virus de la hepatitis C en un centro de reducción de daños

Open Date: 2021-01-01

Close Date: 2022-01-01

Grant: Close

Estudio de la disfunción de la respuesta inmune adaptativa periférica e intrahepática en las diferentes fases de la infección crónica por el virus de la hepatitis B

Open Date: 2018-01-01

Close Date: 2020-01-01

Grant: Close

Estudio de los factores virológicos e inmunológicos relacionados con la recurrencia de la infección por los virus de la hepatitis C y B tras la interrupción del tratamiento antiviral

Open Date: 2015-01-01

Close Date: 2017-01-01

Grant: Close

Viral hepatitis in the immunocompetent host and in the liver transplant recipient

Open Date: 2014-01-01

Close Date: 2016-01-01

Grant: Close

Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial (HepaMAb).

Open Date: 2013-01-01

Close Date: 2017-01-01

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Ferran Torres

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Maria Reig

Head of the Liver Oncology group-CIBER

SPAIN

View details

JOSE CASTELLOTE

Head of Unit

Hospital Universitari de Bellvitge

SPAIN

View details

Caridad Pontes

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Rafael Artuch

MD, PhD.. Head of clinical biochemistry Department

Hospital de la Santa Creu i Sant Pau

SPAIN

View details

Elisa del Pilar Rodríguez Seguel

Profesora permanente laboral

Universidad de Sevilla

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xavier Forns

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

Letter: Drug‐Induced Autoimmune‐Like Hepatitis—A Trigger on the Disease Spectrum. Authors' Reply

Rat hepatitis E: A silent threat or overestimated risk?

Unveiling the Hidden Risk: Herbal and Dietary Supplement Consumption in Liver Disease Patients

Exchangeable copper for patients with Wilson disease at follow-up: Rethinking normal ranges or changing methodology

Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease

Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study

EASL position paper on clinical follow-up after HCV cure

Benefits of using exchangeable copper and the ratio of exchangeable copper in a real‐world cohort of patients with Wilson disease

The relevance of finding biomarkers to identify the best candidates for nucleos(t)ide analogue discontinuation in HBeAg-negative chronic hepatitis B

Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts

Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination

Elastography is unable to exclude cirrhosis after sustained virological response in HCV‐infected patients with advanced chronic liver disease

Reply to: Optimal hepatitis B vaccination schedule for cirrhotic patients: a still unanswered question

Efficacy of an accelerated double‐dose hepatitis B vaccine regimen in patients with cirrhosis

Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy

Can hepatitis A outbreaks in men who have sex with men be controlled?,¿Es posible el control de los brotes de hepatitis A en hombres que tienen sexo con hombres?

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8<sup>+</sup> T cells after direct-acting antiviral therapies

Collaborators (6)

Ferran Torres

Maria Reig

JOSE CASTELLOTE

Caridad Pontes

Rafael Artuch

Elisa del Pilar Rodríguez Seguel

Make your next move.